REGIMEN

作品数：321被引量：567H指数：13
导出分析报告
相关领域：医药卫生更多>>
相关作者：李佳妮于锋葛卫红邱实陈珊更多>>
相关机构：广东省心血管病研究所北京协和医院东南大学中国药科大学更多>>
相关期刊：更多>>
相关基金：国家自然科学基金北京市自然科学基金国家重点基础研究发展计划上海市自然科学基金更多>>
-
在结果中检索

检索结果分析

结果分析中...
共 条 记 录，以下是1-10
全选清除导出
参考文献引证文献引用追踪
视图：
排序：
Novel multimodal analgesic regimen for perioperative pain management after hepatic artery infusion chemotherapy in patients with advanced hepatocellular carcinoma
《World Journal of Gastrointestinal Surgery》2025年第4期271-282,共12页Jing Yan Rui An Jing-Jing Wang Min Wang Qi Zhao Shen Zhao Jian Xu 
Supported by Beijing Medical Award Foundation of China,No.YXJL-2023-0638-0048.
BACKGROUND Hepatic artery infusion chemotherapy(HAIC)is a widely used local therapeutic approach for intermediate to advanced-stage hepatocellular carcinoma(HCC),exhibiting considerable efficacy.However,the prevalence...
关键词：Advanced hepatocellular carcinoma Hepatic artery infusion chemotherapy Multimodal analgesia regimen Postoperative pain Pain improvement 
Nab-paclitaxel plus capecitabine as a first-line regimen for advanced biliary tract cancers:Feasible or not feasible?
《World Journal of Gastroenterology》2025年第10期134-138,共5页Jian-Qiang Chen Xiang Lan 
A clinical trial of nab-paclitaxel plus capecitabine as a first-line treatment for advanced biliary tract cancers was conducted.We analyzed the development of systemic therapy recommended by the National Comprehensive...
关键词：NAB-PACLITAXEL CAPECITABINE Biliary tract cancers Systemic therapy Firstline regimen 
Improved treatment of colorectal liver metastases by early response evaluation and regimen adjustment:a prospective study of clinical functional MR-based modeling
《Cancer Biology & Medicine》2025年第2期166-176,共11页Wenhua Li Huan Zhang Zhe Gong Yue Li Zhiyu Chen Xiaodong Zhu Mingzhu Huang Zhe Zhang Chenchen Wang Lixin Qiu Qirong Geng Jinjia Chang Xiaoying Zhao Xuedan Sheng Wen Zhang Tong Tong Weijian Guo 
supported by the National Natural Science Foundation of China(Grant nos.82271946 and 82202101);Innovative Achievement Transformation of Shenkang MedicalEnterprise Integration(Grant no.SHDC2023CRD014)。
Objective:The aim of the study was to evaluate the feasibility of functional MR in predicting the clinical response to chemotherapy in patients with colorectal liver metastases(CLM).Methods:A total of 196 eligible pat...
关键词：Colorectal cancer liver metastases objective response rate MR 
Efficacy,safety and treatment satisfaction of transition to a regimen of insulin degludec/aspart:A pilot study
《World Journal of Diabetes》2025年第1期65-73,共9页Na Yang Lu Lv Shu-Meng Han Li-Yun He Zi-Yi Li Yu-Cheng Yang Fan Ping Ling-Ling Xu Wei Li Hua-Bing Zhang Yu-Xiu Li 
Supported by CAMS Innovation Fund for Medical Sciences,No.2023-I2M-C&T-B-043;National High Level Hospital Clinical Research Funding,No.2022-PUMCH-B-015;CAMS Innovation Fund for Medical Sciences,No.2021-1-12M-002;Beijing Municipal Natural Science Foundation,No.M22014.
BACKGROUND There is a lack of clinical evidence on the efficacy and safety of transitioning from a thrice-daily pre-mixed insulin or basal-prandial regimen to insulin degludec/aspart(IDegAsp)therapy,with insufficient ...
关键词：Insulin degludec/aspart Type 2 diabetes management Basal-bolus insulin therapy Pre-mixed insulin Diabetes treatment satisfaction questionnaire 
Temozolomide and capecitabine regimen as first-line treatment in advanced gastroenteropancreatic neuroendocrine tumors at a Latin American reference center
《World Journal of Gastrointestinal Oncology》2024年第12期4675-4684,共10页Wagner Eduardo Cruz-Diaz Victor Paitan Jersinho Medina Raymundo Flores Juan Haro-Varas Raul Mantilla Victor Castro-Oliden 
BACKGROUND Numerous studies have indicated that the temozolomide and capecitabine regimen(TEMCAP)exhibits a certain level of efficacy in treating advanced,welldifferentiated gastroenteropancreatic neuroendocrine tumor...
关键词：WELL-DIFFERENTIATED Gastroenteropancreatic neuroendocrine tumors CAPECITABINE TEMOZOLOMIDE Retrospective study Treatment CHEMOTHERAPY 
Systematic review:bevacizumab combined with radiotherapy regimen in NSCLC patients,modulating VEGF/VEGFR2 signaling
《Journal of Chinese Pharmaceutical Sciences》2024年第12期1137-1145,共9页Zhangpeng Song Feng Zhou Yangyong Zhang Jie Zhang Yuan Feng 
To assess the efficacy of radiotherapy combined with bevacizumab compared to radiotherapy alone in patients with non-small cell lung cancer(NSCLC)and to explore its impact on anti-tumor neovascularization,we conducted...
关键词：one Bevacizumab combined with radiotherapy NSCLC VEGF VEGFR Clinical effect 
Human immunodeficiency virus/acquired immune deficiency syndrome antiretroviral therapy initiated on the same day in treatment-naïve people with human immunodeficiency virus:A comparative study of efficacy and regimen被引量：2
《Chinese Medical Journal》2024年第22期2720-2725,共6页Jing Yuan Changgang Deng Qisui Li Yanyu Sun Wei Huang Wei Zhang Min Liu 
supported by grants from the first batch of the Key Public Health Key Discipline Construction Project(Junior College);the Chongqing Kewei Traditional Chinese Medicine Technology Innovation and Application Development Project(No.2021ZY4265).
Background:Rapid initiation of antiretroviral therapy(ART)is recommended by guidelines,however,real-world studies of same-day initiation of ART in China are limited,and an optimal treatment regimen has yet to be ident...
关键词：HIV/AIDS Same-day initiation Antiretroviral therapy Treatment retention Regimen retention 
Effectiveness of switching to bictegravir/emtricitabine/tenofovir alafenamide in virologically suppressed people with HIV with historical drug resistance mutations
《Chinese Medical Journal》2024年第22期2758-2760,共3页Ziwei Chang Hongyan Zhu Yiting Zhang Yaling Chen Jiahui Li Jiamin Qin Yueping Zhu Hongxia Wei Yongfeng Yang Meiyin Zou Feng Qian Zhiliang Hu 
This study was funded in part by the project of Nanjing Infectious Disease Clinical Medical Center and the project of Innovation center for infectious disease of Jiangsu Province(NO.CXZX202232);the Jiangsu Provincial Health Commission Medical Research Foundation(No.M2022030);the Nanjing Medical Science and Technique Development Foundation(No.ZKX21037);the Research Project of Nantong Municipal Health Commission(No.MS2023077).
To the Editor:China provides free antiretroviral therapy(ART)for people with human immunodeficiency virus(HIV),typically using two nucleoside reverse transcriptase inhibitors(NRTIs)and one non-nucleoside reverse trans...
关键词：mortality REGIMEN resistance 
What Mice Can Teach Us about How to Stop Drug-Resistant Tuberculosis:Correct Chemotherapy Regimen and Patient Compliance are the Key
《Biomedical and Environmental Sciences》2024年第9期1086-1090,共5页Igor Mokrousov Tatiana Vinogradova Marine Dogonadze Maria Vitovskaya Natalia Zabolotnykh Sergei Chekrygin Anna Vyazovaya 
Despite well-known limitations,mice remain useful as model animals to study tuberculosis(TB)pathogenesis,the basic immune response,the extent of lung pathology as well as efficacy of new drugs against Mycobacterium tu...
关键词：TUBERCULOSIS DRUGS injection 
Clinical analysis of adverse reactions in patients with multidrug-resistant and rifampicin-resistant pulmonary tuberculosis treated with delamanid-containing regimen
《China Medical Abstracts(Internal Medicine)》2024年第3期168-169,共2页GAO Mengqiu 
Objective To explore the characteristics of adverse drug reactions during the 24-week therapy with delamanid-containing regimen for patients with multidrug-resistant and rifampicin-resistant pulmonary tuberculosis(MDR...
关键词：TUBERCULOSIS REGIMEN PATIENTS 
全选清除导出
共32页<12345678910>
检索报告 对象比较 聚类工具 使用帮助 返回顶部